Antihistamine News and Research

RSS
Antihistamine is a type of drug that blocks the action of histamines, which can cause fever, itching, sneezing, a runny nose, and watery eyes. Antihistamines are used to prevent fevers in patients receiving blood transfusions and to treat allergies, coughs, and colds.
Merck reports non-GAAP EPS of $0.83 for first-quarter 2010

Merck reports non-GAAP EPS of $0.83 for first-quarter 2010

New strategies to help allergy sufferers survive the winds of spring, summer

New strategies to help allergy sufferers survive the winds of spring, summer

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Merck announces global sales of $27.4 billion for full-year 2009

Merck announces global sales of $27.4 billion for full-year 2009

AMRI announces fourth-quarter and full-year 2009 results

AMRI announces fourth-quarter and full-year 2009 results

Lanzoprazole and astemizole hold promise for early detection of AD

Lanzoprazole and astemizole hold promise for early detection of AD

Sanofi-aventis to acquire Chattem for $1.9 billion

Sanofi-aventis to acquire Chattem for $1.9 billion

NeoPharm presents LE-DT Phase I data at the AACR conference

NeoPharm presents LE-DT Phase I data at the AACR conference

AMRI reports $47.7 million total revenue for the third quarter of 2009

AMRI reports $47.7 million total revenue for the third quarter of 2009

Schering-Plough announces 2009 third quarter financial results

Schering-Plough announces 2009 third quarter financial results

Azelastine and fluticasone combination for allergic rhinitis gets new lease

Azelastine and fluticasone combination for allergic rhinitis gets new lease

FDA approves Meda's ASTEPRO Nasal Spray

FDA approves Meda's ASTEPRO Nasal Spray

FDA approves Astepro nasal spray 0.15% for the treatment of the symptoms of seasonal allergies

FDA approves Astepro nasal spray 0.15% for the treatment of the symptoms of seasonal allergies

UCB and sanofi-aventis U.S. receive FDA's approval for XYZAL to treat allergies in children

UCB and sanofi-aventis U.S. receive FDA's approval for XYZAL to treat allergies in children

Schering-Plough announces agreement with Orchid Chemicals & Pharmaceuticals on generic forms of CLARINEX

Schering-Plough announces agreement with Orchid Chemicals & Pharmaceuticals on generic forms of CLARINEX

Eiger Biopharmaceuticals starts CLEAN-1 HCV phase 1B trial

Eiger Biopharmaceuticals starts CLEAN-1 HCV phase 1B trial

American Oriental Bioengineering launches new product for rhinitis and allergies

American Oriental Bioengineering launches new product for rhinitis and allergies

Itching after burns - study offers best options

Itching after burns - study offers best options

Sun Pharmaceutical receives FDA approvals for 4 generics

Sun Pharmaceutical receives FDA approvals for 4 generics

Pain and itch regulated by different molecular mechanisms

Pain and itch regulated by different molecular mechanisms